04:34 AM EDT, 07/02/2025 (MT Newswires) -- ArriVent BioPharma ( AVBP ) said late Tuesday it priced a $75 million offering, issuing about 2.5 million shares at $19.50 apiece and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to roughly 1.4 million shares.

The company granted underwriters a 30-day option to purchase up to 576,923 additional shares.

Proceeds will support, among other things, the development of the company's lead oncology asset, firmonertinib.

The offering is expected to close on or about Thursday.